Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models

Tsukasa Nozu(Asahikawa Medical University), Toshikatsu Okumura(Asahikawa Medical College Hospital)
International Immunopharmacology
April 20, 2024
Cited by 11


Related Papers